To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task…

Active Indefinite Delivery Contract Awarded Last action

Contract number
75N94020D00004
Awardee
Awarding agency
Task orders
3 $785,569 obligated

Award facts

Combined order value
  • $785,569 Current, with exercised options
  • $904,857 Potential, with all options
Last date to order 89% complete
IDV ceiling 16% used
$5,000,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 18 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Legislative mandates

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Child Health and Human Development awarded an indefinite-delivery contract to Boston Medical Center Corporation on August 1, 2020, with a $5 million ceiling as a multiple-award vehicle to conduct Phase I, II, III, or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task-order basis.

Place of performance is Roxbury, Massachusetts. The contract period of performance extends through July 31, 2027.

Recent task-order activity includes a Phase 2b study evaluating the efficacy and safety of subcutaneous levonorgestrel butanoate for female contraception (ceiling $719,094.93, issued August 1, 2025, completion March 31, 2029); an Ovaprene Vaginal Device Clinical Trial Phase 1 order for protocol finalization and procurement of regulatory approvals (ceiling $113,357.02, issued September 28, 2023, completion February 28, 2026); and core function activities supporting the development of new contraceptive products through protocol review, protocol development, and Contraceptive Clinical Trials Network activities (ceiling $72,404.90, issued August 1, 2020, completion July 31, 2027). All task orders are priced on a cost-no-fee basis and performed at the Roxbury location.

Description

To conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or leiomyomata, and development of research protocols on a task order basis.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00002 · Nichd: r & d: to conduct phase i, II, III or IV contraceptive trials in women, treatment trials of gynecologic conditions such as endometriosis or… $0
Other Administrative Action P00001 $0
Original award $0

Quick answers

Who was awarded contract 75N94020D00004?

75N94020D00004 was awarded to Boston Medical Center Corporation by National Institute of Child Health and Human Development (National Institutes of Health) on August 1, 2020.

How much is contract 75N94020D00004 worth?

Orders under 75N94020D00004 have obligated $785,569. Their combined potential value, with all options, is $904,857. 75N94020D00004's own ceiling is $5,000,000.

How many orders have been placed under contract 75N94020D00004?

3 orders have been placed under 75N94020D00004, the latest on August 1, 2025.

Who can order from contract 75N94020D00004?

75N94020D00004 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N94020D00004 competed?

The extent of competition for 75N94020D00004 was full and open competition. The government received 18 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV